[Control of ATP levels in stimulated pancreatic B-cells].
D000255:Adenosine Triphosphate / Q000032:analysis* / Q000378:metabolism; D000818:Animals; D002087:Butyrates / Q000494:pharmacology; D002271:Carbutamide / Q000494:pharmacology; D000242:Cyclic AMP / Q000032:analysis / Q000494:pharmacology; D003981:Diazoxide / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005934:Glucagon / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D006003:Glycogen / Q000032:analysis; D006651:Histocytochemistry; D007004:Hypoglycemic Agents / Q000494:pharmacology; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007511:Ischemia / Q000503:physiopathology; D007515:Islets of Langerhans / Q000032:analysis* / Q000187:drug effects / Q000378:metabolism; D051379:Mice; D009765:Obesity; D010182:Pancreatic Diseases / Q000503:physiopathology; D013449:Sulfonamides / Q000494:pharmacology; D013806:Theophylline / Q000494:pharmacology
D002087:Butyrates; D007004:Hypoglycemic Agents; D007328:Insulin; D013449:Sulfonamides; D000255:Adenosine Triphosphate; D006003:Glycogen; D005934:Glucagon; D013806:Theophylline; D000242:Cyclic AMP; D002271:Carbutamide; D005947:Glucose; D003981:Diazoxide; D004837:Epinephrine